HR 1613 118th Congress House Health Business records Congressional oversight Government information and archives Health care costs and insurance Home and outpatient care Inflation and prices Medicaid Prescription drugs Public contracts and procurement Retail and wholesale trades State and local government operations User charges and fees

Drug Price Transparency in Medicaid Act of 2023

Introduced: May 16, 2023 Introduced by: Carter, Earl L. "Buddy" Republican · Georgia See on congress.gov

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Mar 24, 2023

Referred to the Subcommittee on Health.

Mar 17, 2023

Referred to the House Committee on Energy and Commerce.

Mar 17, 2023

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Drug Price Transparency in Medicaid Act of 2023

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.

What's happening now March 24, 2023

Referred to the Subcommittee on Health.

Related & companion bills 2

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 2

Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee

Lobbying activity 12

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

THE KROGER CO.
for KROGER CO · Ohio · 1st Quarter (Jan 1 - Mar 31) 2026
THE KROGER CO.
for KROGER CO · Ohio · 4th Quarter (Oct 1 - Dec 31) 2025
THE METROHEALTH SYSTEM
for THE METROHEALTH SYSTEM · Ohio · 4th Quarter (Oct 1 - Dec 31) 2025
THE METROHEALTH SYSTEM
for THE METROHEALTH SYSTEM · Ohio · 4th Quarter (Oct 1 - Dec 31) 2025
THE METROHEALTH SYSTEM
for THE METROHEALTH SYSTEM · Ohio · 3rd Quarter (July 1 - Sep 30) 2025
THE KROGER CO.
for KROGER CO · Ohio · 3rd Quarter (July 1 - Sep 30) 2025

See all 12 filings →

Cosponsors 36

Morelle, Joseph D.

New York · Sep 12, 2024

Budzinski, Nikki

Illinois · Aug 6, 2024

Edwards, Chuck

North Carolina · Jun 21, 2024

Cartwright, Matt

· Jun 18, 2024

Suozzi, Thomas R.

New York · Apr 17, 2024

LaLota, Nick

New York · Aug 22, 2023

Bentz, Cliff

Oregon · Jul 20, 2023

New York · May 24, 2023

Meuser, Daniel

Pennsylvania · May 22, 2023

Rogers, Mike D.

Alabama · May 22, 2023

Perez, Marie Gluesenkamp

Washington · May 17, 2023

Carl, Jerry

· May 16, 2023

Dunn, Neal P.

Florida · May 16, 2023

Mann, Tracey

Kansas · May 10, 2023

Lawler, Michael

New York · May 5, 2023

Bacon, Don

Nebraska · May 2, 2023

Bishop, Sanford D.

Georgia · Apr 28, 2023

Thompson, Glenn

Pennsylvania · Apr 27, 2023

Alford, Mark

Missouri · Apr 26, 2023

Harris, Andy

Maryland · Apr 26, 2023

Tlaib, Rashida

Michigan · Apr 26, 2023

Miller-Meeks, Mariannette

Iowa · Apr 25, 2023

Langworthy, Nicholas A.

New York · Apr 18, 2023

Peters, Scott H.

California · Apr 18, 2023

Harshbarger, Diana

Tennessee · Apr 17, 2023

Malliotakis, Nicole

New York · Apr 13, 2023

Williams, Roger

Texas · Apr 13, 2023

Krishnamoorthi, Raja

Illinois · Apr 3, 2023

Mills, Cory

Florida · Mar 27, 2023

Allen, Rick W.

Georgia · Mar 17, 2023

Auchincloss, Jake

Massachusetts · Mar 17, 2023

Gonzalez, Vicente

Texas · Mar 17, 2023

Ross, Deborah K.

North Carolina · Mar 17, 2023

Stefanik, Elise M.

New York · Mar 17, 2023

Cite this page click to expand

APA

U.S. Congress. (2026). H.R. 1613: Drug Price Transparency in Medicaid Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-1613/

MLA

"H.R. 1613: Drug Price Transparency in Medicaid Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-1613/.

Bluebook (legal)

H.R. 1613, 118th Cong. (2026), https://openamerica.io/bill/118-HR-1613/.

Markdown link

[H.R. 1613: Drug Price Transparency in Medicaid Act of 2023](https://openamerica.io/bill/118-HR-1613/)